Q2 2025 Holdings
Filed 2025-08-14 | 44 holdings | $2.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $932.3M | 19,751,284 | 33.3% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $240.1M | 5,502,710 | 8.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $183.3M | 4,982,384 | 6.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $177.5M | 3,211,041 | 6.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $176.4M | 1,690,221 | 6.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $140.5M | 2,761,333 | 5.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $107.6M | 8,827,712 | 3.8% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $75.6M | 1,913,385 | 2.7% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $65.3M | 2,590,303 | 2.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $54.1M | 4,308,935 | 1.9% |
| Septerna Inc(SEPN) | COM | 81734D104 | $46.5M | 4,396,124 | 1.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $46.3M | 3,466,000 | 1.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $44.7M | 7,754,129 | 1.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $43.3M | 5,750,683 | 1.5% |
| AC Immune SA(ACIU) | SHS | H00263105 | $40.2M | 19,822,436 | 1.4% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $38.3M | 786,392 | 1.4% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $37.7M | 3,944,194 | 1.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $36.7M | 1,771,417 | 1.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $32.1M | 1,024,288 | 1.1% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $25.5M | 5,660,132 | 0.9% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $24.9M | 5,302,000 | 0.9% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $22.6M | 5,295,893 | 0.8% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $22.4M | 1,387,863 | 0.8% |
| Xencor Inc(XNCR) | COM | 98401F105 | $21.5M | 2,740,141 | 0.8% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $17.2M | 4,629,289 | 0.6% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $17.1M | 6,293,282 | 0.6% |
| Annexon Inc(ANNX) | COM | 03589W102 | $16.8M | 7,000,000 | 0.6% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $15.7M | 696,555 | 0.6% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $14.9M | 8,748,629 | 0.5% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $14.4M | 10,333,600 | 0.5% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $14.1M | 3,404,425 | 0.5% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $9.2M | 1,154,692 | 0.3% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $7.6M | 588,344 | 0.3% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $7.6M | 5,226,074 | 0.3% |
| Ikena Oncology Inc | COM | 45175G108 | $5.4M | 4,006,564 | 0.2% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $5.3M | 7,652,972 | 0.2% |
| Molecular Partners AG(MOLN) | ADS | 60853G106 | $5.2M | 1,353,968 | 0.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $5.1M | 1,028,049 | 0.2% |
| Inventiva SA(IVA) | ADS | 46124U107 | $2.1M | 686,040 | 0.1% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $2.0M | 339,549 | 0.1% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $1.6M | 917,826 | 0.1% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $1.3M | 3,853,818 | 0.0% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $586.1K | 945,402 | 0.0% |
| NLS Pharmaceutics LTD | COM NEW | H57830137 | $416.7K | 143,676 | 0.0% |